Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 149

1.

Imaging the clear cell renal cell carcinoma proteome.

Morgan TM, Seeley EH, Fadare O, Caprioli RM, Clark PE.

J Urol. 2013 Mar;189(3):1097-103. doi: 10.1016/j.juro.2012.09.074. Epub 2012 Sep 23.

2.

Diagnostic biomarkers for renal cell carcinoma: selection using novel bioinformatics systems for microarray data analysis.

Osunkoya AO, Yin-Goen Q, Phan JH, Moffitt RA, Stokes TH, Wang MD, Young AN.

Hum Pathol. 2009 Dec;40(12):1671-8. doi: 10.1016/j.humpath.2009.05.006. Epub 2009 Aug 19.

3.

Proteomic analysis of clear cell renal cell carcinoma. Identification of potential tumor markers.

Sun CY, Zang YC, San YX, Sun W, Zhang L.

Saudi Med J. 2010 May;31(5):525-32.

PMID:
20464042
4.

Molecular analysis of tumor margins by MALDI mass spectrometry in renal carcinoma.

Oppenheimer SR, Mi D, Sanders ME, Caprioli RM.

J Proteome Res. 2010 May 7;9(5):2182-90. doi: 10.1021/pr900936z.

5.

Identification of novel epigenetic markers for clear cell renal cell carcinoma.

Dalgin GS, Drever M, Williams T, King T, DeLisi C, Liou LS.

J Urol. 2008 Sep;180(3):1126-30. doi: 10.1016/j.juro.2008.04.137. Epub 2008 Jul 18.

PMID:
18639284
6.

Differential protein expressions in renal cell carcinoma: new biomarker discovery by mass spectrometry.

Siu KW, DeSouza LV, Scorilas A, Romaschin AD, Honey RJ, Stewart R, Pace K, Youssef Y, Chow TF, Yousef GM.

J Proteome Res. 2009 Aug;8(8):3797-807. doi: 10.1021/pr800389e.

PMID:
19610612
7.

Diagnostic and prognostic tissuemarkers in clear cell and papillary renal cell carcinoma.

Kroeze SG, Bijenhof AM, Bosch JL, Jans JJ.

Cancer Biomark. 2010;7(6):261-8. doi: 10.3233/CBM-2010-0195. Review.

PMID:
21694464
8.

Novel breast cancer biomarkers identified by integrative proteomic and gene expression mapping.

Ou K, Yu K, Kesuma D, Hooi M, Huang N, Chen W, Lee SY, Goh XP, Tan LK, Liu J, Soon SY, Bin Abdul Rashid S, Putti TC, Jikuya H, Ichikawa T, Nishimura O, Salto-Tellez M, Tan P.

J Proteome Res. 2008 Apr;7(4):1518-28. doi: 10.1021/pr700820g. Epub 2008 Mar 5.

PMID:
18318472
9.

Application of SELDI-TOF-MS to identify serum biomarkers for renal cell carcinoma.

Xu G, Xiang CQ, Lu Y, Kang XN, Liao P, Ding Q, Zhang YF.

Cancer Lett. 2009 Sep 18;282(2):205-13. doi: 10.1016/j.canlet.2009.03.017. Epub 2009 Apr 11.

PMID:
19362769
10.

Quantitative proteomic analysis to discover potential diagnostic markers and therapeutic targets in human renal cell carcinoma.

Okamura N, Masuda T, Gotoh A, Shirakawa T, Terao S, Kaneko N, Suganuma K, Watanabe M, Matsubara T, Seto R, Matsumoto J, Kawakami M, Yamamori M, Nakamura T, Yagami T, Sakaeda T, Fujisawa M, Nishimura O, Okumura K.

Proteomics. 2008 Aug;8(15):3194-203. doi: 10.1002/pmic.200700619.

PMID:
18615424
11.

[Screening urine markers of renal cell carcinoma using SELDI-TOF-MS].

Wu DL, Wang WJ, Guan M, Jin SB, Jin CR, Zhang YF.

Zhonghua Yi Xue Za Zhi. 2004 Jul 2;84(13):1092-5. Chinese.

PMID:
15312509
12.

Panel of candidate biomarkers for renal cell carcinoma.

Kim DS, Choi YP, Kang S, Gao MQ, Kim B, Park HR, Choi YD, Lim JB, Na HJ, Kim HK, Nam YP, Moon MH, Yun HR, Lee DH, Park WM, Cho NH.

J Proteome Res. 2010 Jul 2;9(7):3710-9. doi: 10.1021/pr100236r.

PMID:
20455597
13.

MALDI imaging on tissue microarrays identifies molecular features associated with renal cell cancer phenotype.

Steurer S, Seddiqi AS, Singer JM, Bahar AS, Eichelberg C, Rink M, Dahlem R, Huland H, Sauter G, Simon R, Minner S, Burandt E, Stahl PR, Schlomm T, Wurlitzer M, Schlüter H.

Anticancer Res. 2014 May;34(5):2255-61.

PMID:
24778028
14.

Genomic expression and single-nucleotide polymorphism profiling discriminates chromophobe renal cell carcinoma and oncocytoma.

Tan MH, Wong CF, Tan HL, Yang XJ, Ditlev J, Matsuda D, Khoo SK, Sugimura J, Fujioka T, Furge KA, Kort E, Giraud S, Ferlicot S, Vielh P, Amsellem-Ouazana D, Debré B, Flam T, Thiounn N, Zerbib M, Benoît G, Droupy S, Molinié V, Vieillefond A, Tan PH, Richard S, Teh BT.

BMC Cancer. 2010 May 12;10:196. doi: 10.1186/1471-2407-10-196.

15.

Identification of alphaB-crystallin, a biomarker of renal cell carcinoma by SELDI-TOF MS.

Holcakova J, Hernychova L, Bouchal P, Brozkova K, Zaloudik J, Valik D, Nenutil R, Vojtesek B.

Int J Biol Markers. 2008 Jan-Mar;23(1):48-53.

PMID:
18409151
16.

Systematic comparative protein expression profiling of clear cell renal cell carcinoma: a pilot study based on the separation of tissue specimens by two-dimensional gel electrophoresis.

Lichtenfels R, Dressler SP, Zobawa M, Recktenwald CV, Ackermann A, Atkins D, Kersten M, Hesse A, Puttkammer M, Lottspeich F, Seliger B.

Mol Cell Proteomics. 2009 Dec;8(12):2827-42. doi: 10.1074/mcp.M900168-MCP200. Epub 2009 Sep 14.

17.

Alterations of the serum peptidome in renal cell carcinoma discriminating benign and malignant kidney tumors.

Gianazza E, Chinello C, Mainini V, Cazzaniga M, Squeo V, Albo G, Signorini S, Di Pierro SS, Ferrero S, Nicolardi S, van der Burgt YE, Deelder AM, Magni F.

J Proteomics. 2012 Dec 5;76 Spec No.:125-40. doi: 10.1016/j.jprot.2012.07.032. Epub 2012 Jul 31.

PMID:
22868251
18.

Use of quantitative shotgun proteomics to identify fibronectin 1 as a potential plasma biomarker for clear cell carcinoma of the kidney.

Yokomizo A, Takakura M, Kanai Y, Sakuma T, Matsubara J, Honda K, Naito S, Yamada T, Ono M.

Cancer Biomark. 2011-2012;10(3-4):175-83. doi: 10.3233/CBM-2012-0243.

PMID:
22674303
19.

Imaging mass spectrometry in papillary thyroid carcinoma for the identification and validation of biomarker proteins.

Min KW, Bang JY, Kim KP, Kim WS, Lee SH, Shanta SR, Lee JH, Hong JH, Lim SD, Yoo YB, Na CH.

J Korean Med Sci. 2014 Jul;29(7):934-40. doi: 10.3346/jkms.2014.29.7.934. Epub 2014 Jul 11.

20.

Proteomic identification of angiomotin by ProteomeLab PF-2D and correlation with clinical outcome in human clear cell renal cell carcinoma.

Yang J, Liu P, Tian M, Li Y, Chen W, Li X.

Int J Oncol. 2013 Jun;42(6):2078-86. doi: 10.3892/ijo.2013.1889. Epub 2013 Apr 10.

PMID:
23588948
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk